Inventor
HUDKINS ROBERT L
US77 patents
⚠️ This page may combine multiple inventors who share the name “HUDKINS ROBERT L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CEPHALON INC
29 patentsUS6630500B2Oct 7, 2003
Selected fused pyrrolocarbazoles
CEPHALON INC162 citations98
US6399780B1Jun 4, 2002
Isomeric fused pyrrolocarbazoles and isoindolones
CEPHALON INC61 citations96
US6127401AOct 3, 2000
Bridged indenopyrrolocarbazoles
CEPHALON INC49 citations96
US5705511AJan 6, 1998
Fused pyrrolocarbazoles
CEPHALON INC100 citations96
US5591855AJan 7, 1997
Fused pyrrolocarbazoles
CEPHALON INC115 citations96
US5475110ADec 12, 1995
Fused Pyrrolocarbazoles
CEPHALON INC93 citations96
US7074793B2Jul 11, 2006
Cyclic substituted fused pyrrolocarbazoles and isoindolones
CEPHALON INC60 citations95
US5616724AApr 1, 1997
Fused pyrrolo[2,3-c]carbazole-6-ones
CEPHALON INC51 citations95
US5594009AJan 14, 1997
Fused pyrrolocarbazoles
CEPHALON INC63 citations94
US7169802B2Jan 30, 2007
Fused pyrrolocarbazoles
CEPHALON INC18 citations92
US6359130B1Mar 19, 2002
Bridged indenopyrrolocarbazoles
CEPHALON INC48 citations92
US5808060ASep 15, 1998
Fused isoindolones
CEPHALON INC26 citations92
US5801190ASep 1, 1998
Fused pyrrolo 2,3-C! carbazole-6-ones
CEPHALON INC26 citations92
US6306849B1Oct 23, 2001
Selected derivatives of K-252a
CEPHALON INC35 citations91
US5516772AMay 14, 1996
K-252 derivatives which enhance neurotrophin-induced activity
CEPHALON INC38 citations90
US6448283B1Sep 10, 2002
Methods for preventing/treating damage to sensory hair cells and cochlear neurons
CEPHALON INC29 citations87
US9902696B2Feb 27, 2018
1,4-substituted piperidine derivatives
CEPHALON INC7 citations83
US7241779B2Jul 10, 2007
Fused pyrrolocarbazoles
CEPHALON INC13 citations83
US7122679B2Oct 17, 2006
Multicyclic compounds and the use thereof
CEPHALON INC14 citations83
US5650407AJul 22, 1997
Selected soluble esters of hydroxyl-containing indolocarbazoles
CEPHALON INC9 citations74
US7671064B2Mar 2, 2010
Fused pyrrolocarbazoles
CEPHALON INC7 citations73
US6451786B1Sep 17, 2002
3′-epimeric k-252a derivatives
CEPHALON INC8 citations73
US6841567B1Jan 11, 2005
Cyclic substituted fused pyrrolocarbazoles and isoindolones
CEPHALON INC7 citations72
US7291732B2Nov 6, 2007
Isomeric fused pyrrolocarbazoles and isoindolones
CEPHALON INC1 citations63
US6872746B2Mar 29, 2005
Isomeric fused pyrrolocarbazoles and isoindolones
CEPHALON INC3 citations63
US6635669B2Oct 21, 2003
Isomeric fused pyrrolocarbazoles and isoindolones
CEPHALON INC4 citations63
US5686444ANov 11, 1997
Selected soluble esters of hydroxyl-containing indolocarbazoles
CEPHALON INC2 citations63
US7230026B2Jun 12, 2007
Selected fused pyrrolocarbazoles
CEPHALON INC2 citations62
US7115613B2Oct 3, 2006
Selected fused pyrrolocarbazoles
CEPHALON INC2 citations62
89BIO LTD
7 patentsUS10851057B2Dec 1, 2020
1,4-substituted piperidine derivatives
89BIO LTD5 citations83
US10221135B2Mar 5, 2019
1,4-substituted piperidine derivatives
89BIO LTD7 citations83
US11702388B2Jul 18, 2023
1,4-substituted piperidine derivatives
89BIO LTD3 citations72
US10919875B2Feb 16, 2021
Substituted 4-benzyl and 4-benzoyl piperidine derivatives
89BIO LTD4 citations72
US11046707B2Jun 29, 2021
Spiropiperidine derivatives
89BIO LTD4 citations71
US12448392B2Oct 21, 2025
Spiropiperidine derivatives
89BIO LTD0 citations61
US11878966B2Jan 23, 2024
Substituted 4-benzyl and 4-benzoyl piperidine derivates
89BIO LTD0 citations61
IGNYTA INC
6 patentsUS9522902B2Dec 20, 2016
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC4 citations83
US9120778B2Sep 1, 2015
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC5 citations83
US9029538B2May 12, 2015
Uracil derivatives as AXL and c-MET kinase inhibitors
IGNYTA INC8 citations83
US9914730B2Mar 13, 2018
Azaquinazoline inhibitors of Atypical protein Kinase C
IGNYTA INC6 citations81
US9896446B2Feb 20, 2018
Azaquinazoline inhibitors of atypical protein kinase C
IGNYTA INC4 citations70
US10028956B2Jul 24, 2018
Methods of treating various cancers using an AXL/cMET inhibitor in combination with other agents
IGNYTA INC2 citations65
BACON EDWARD R
3 patentsUS8673916B2Mar 18, 2014
Methods of treating disorders mediated by histamine H3 receptors using pyridazinone derivatives
BACON EDWARD R7 citations82
US8513232B2Aug 20, 2013
Substituted spirocyclic piperidine derivatives as histamine-3 (H3) receptor ligands
BACON EDWARD R9 citations82
US8247414B2Aug 21, 2012
Pyridizinone derivatives and the use thereof as H3 inhibitors
BACON EDWARD R2 citations62
NOVA PHARM CORP
1 patentKYOWA HAKKO KOGYO KK
1 patentBECKNELL NADINE C
1 patentCHATTERJEE SANKAR
1 patentCEPHALON LLC
1 patentShowing the top 50 of 77 patents by PatentIndex Score.